Ovarian epithelial carcinoma tyrosine phosphorylation, cell proliferation, and ezrin translocation are stimulated by interleukin 1alpha and epidermal growth factor.
about
Plasmodium vivax inhibits erythroid cell growth through altered phosphorylation of the cytoskeletal protein ezrinVariation in gene expression patterns in effusions and primary tumors from serous ovarian cancer patients.Sphingolipid regulation of ezrin, radixin, and moesin proteins family: implications for cell dynamics.Molecular targets for tumour progression in gastrointestinal stromal tumours.Extra-nuclear signalling of estrogen receptor to breast cancer cytoskeletal remodelling, migration and invasionExpression of interleukin-1 (IL-1) ligands system in the most common endometriosis-associated ovarian cancer subtypes.Fascin-1, ezrin and paxillin contribute to the malignant progression and are predictors of clinical prognosis in laryngeal squamous cell carcinoma.Immune response in ovarian cancer: how is the immune system involved in prognosis and therapy: potential for treatment utilization.Ovarian cancer metastasis: integrating insights from disparate model organisms.Ezrin Is Associated with Disease Progression in Ovarian Carcinoma.Upregulated expression of Ezrin and invasive phenotype in malignantly transformed esophageal epithelial cellsEffects of advanced glycation end products on ezrin-dependent functions in LLC-PK1 proximal tubule cells.Activated epidermal growth factor receptor in ovarian cancer.Epidermal growth factor-induced cellular invasion requires sphingosine-1-phosphate/sphingosine-1-phosphate 2 receptor-mediated ezrin activation.Comparative proteomic study of two closely related ovarian endometrioid adenocarcinoma cell lines using cIEF fractionation and pathway analysisAutoantibody biomarkers identified by proteomics methods distinguish ovarian cancer from non-ovarian cancer with various CA-125 levels.Prognostic Value of Ezrin in Various Cancers: A Systematic Review and Updated Meta-analysis.Amphiregulin induces human ovarian cancer cell invasion by down-regulating E-cadherin expression.Ezrin overexpression by transformed human ovarian surface epithelial cells, ovarian cleft cells, and serous ovarian adenocarcinoma cells.The role of the membrane cytoskeleton cross-linker ezrin in medulloblastoma cells.Expression of Ezrin and Estrogen Receptors During Cervical Carcinogenesis.Association of ezrin expression in intestinal and diffuse gastric carcinoma with clinicopathological parameters and tumor type.The cytoskeletal protein ezrin regulates EC proliferation and angiogenesis via TNF-alpha-induced transcriptional repression of cyclin A.Addition of vandetanib to pegylated liposomal doxorubicin (PLD) in patients with recurrent ovarian cancer. A randomized phase I/II study of the AGO Study Group (AGO-OVAR 2.13).The amino-terminal domains of the ezrin, radixin, and moesin (ERM) proteins bind advanced glycation end products, an interaction that may play a role in the development of diabetic complications.Increase in ezrin expression from benign to malignant breast tumours.ERM/Rho protein expression in ductal breast cancer: a 15 year follow-up.
P2860
Q24337035-9FDE5095-6C47-4A8C-9D8E-81BC5080672AQ24816153-ADF629DE-A830-4BC7-B190-B07A78073146Q27691440-25F8EE0C-D0CD-4132-9A84-69DA020B3789Q30312213-B5317FD4-50D3-4B48-82F1-27057AB8864BQ33336567-C0511527-CFDB-4BD0-B4AC-EF3CB462C3C5Q33706144-0E427378-A2E4-449C-A44B-1536D8168EDBQ34500644-A77596C5-8C4D-4F7C-B88F-05B499840A30Q34557233-68C16DBB-F8A1-45C1-8DAC-36C6B39EED0BQ36111930-A04A4D20-F3F8-42FA-80A7-7A979D591823Q36131154-F50B3398-AC13-4797-85D1-1D0704F646FBQ36179753-13D0E348-441E-4AE2-A801-57D75E841132Q36203985-02B24CD6-970E-4B22-B7DA-87EE351495FAQ36981918-7B062E92-5FEA-495E-A867-3EE02B74FE25Q37022926-59901DF4-4562-44AF-9069-A3C7013466E7Q37171613-A36981AD-12D7-46EC-8A2B-089ABBC884DDQ37322280-20354177-A3ED-4458-AE18-1D418FBAF5A0Q38657600-EAEDE214-0BD0-461F-8D4B-1375739D0FF6Q38952915-A480FCD6-DC83-4BCC-8EA9-FC48E8F4929FQ39369110-0848FE33-60FD-41B3-8998-2E478903149AQ39904552-3FDA0CE6-A2C5-4920-9F04-0D17A5A3FFC6Q40521768-A8F13378-185E-4FA6-8043-A432148AFA62Q42090058-FF95B984-5922-4998-9786-598AE1029F47Q42860390-716F4EA3-BB3E-4CC8-883E-07E0552F1C66Q44324783-0881D7BE-543F-49D8-A1F9-06E04369CFA4Q44432075-80E62B55-95EA-419A-A004-5E00A6180D70Q53086422-F75BA8C6-5D55-4F05-A036-7218F3364CAAQ54448812-79EC5E19-9B25-409D-B013-E2702B84F1F4
P2860
Ovarian epithelial carcinoma tyrosine phosphorylation, cell proliferation, and ezrin translocation are stimulated by interleukin 1alpha and epidermal growth factor.
description
2001 nî lūn-bûn
@nan
2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Ovarian epithelial carcinoma t ...... a and epidermal growth factor.
@ast
Ovarian epithelial carcinoma t ...... a and epidermal growth factor.
@en
type
label
Ovarian epithelial carcinoma t ...... a and epidermal growth factor.
@ast
Ovarian epithelial carcinoma t ...... a and epidermal growth factor.
@en
prefLabel
Ovarian epithelial carcinoma t ...... a and epidermal growth factor.
@ast
Ovarian epithelial carcinoma t ...... a and epidermal growth factor.
@en
P2093
P2860
P1433
P1476
Ovarian epithelial carcinoma t ...... a and epidermal growth factor.
@en
P2093
P2860
P304
P356
10.1002/1097-0142(20011215)92:12<3068::AID-CNCR10149>3.0.CO;2-5
P407
P577
2001-12-01T00:00:00Z